APA (7th ed.) Citation

YJ, S., TT, K., YJ, L., YT, C., IC, C., CM, K., . . . YM, C. (2026). Impact of drug-drug interaction of JAK inhibitors, CYP enzyme inhibitors and OAT3 inhibitors on persistence and infection rates in patients with autoimmune rheumatic diseases. Joint bone spine, 93(2), 105990. https://doi.org/10.1016/j.jbspin.2025.105990

Chicago Style (17th ed.) Citation

YJ, Shao, Kuo TT, Liao YJ, Chen YT, Chen IC, Kao CM, Chen YJ, and Chen YM. "Impact of Drug-drug Interaction of JAK Inhibitors, CYP Enzyme Inhibitors and OAT3 Inhibitors on Persistence and Infection Rates in Patients with Autoimmune Rheumatic Diseases." Joint Bone Spine 93, no. 2 (2026): 105990. https://doi.org/10.1016/j.jbspin.2025.105990.

MLA (9th ed.) Citation

YJ, Shao, et al. "Impact of Drug-drug Interaction of JAK Inhibitors, CYP Enzyme Inhibitors and OAT3 Inhibitors on Persistence and Infection Rates in Patients with Autoimmune Rheumatic Diseases." Joint Bone Spine, vol. 93, no. 2, 2026, p. 105990, https://doi.org/10.1016/j.jbspin.2025.105990.